Shurson GC, Urriola PE, Hung YT
Trompier D, Chang XB, Barattin R, du Moulinet DHardemare A, Di Pietro A, Baubichon-Cortay H
The article says GLP-1 agonists stimulate appetite-suppressing neurons in the hypothalamus and slow gastric emptying, and that during menopause this may counteract the reduced satiety signaling caused by estrogen loss
This podcast has become a powerful space where people living with obesity, GLP-1 medication users, clinicians, and advocates share their stories, expertise, and lived experience
While GLP-1s have skyrocketed in popularity for dropping pounds theres actually a world of benefitsand important safety considerationsthat most people dont know about